Oncopeptides AB banner

Oncopeptides AB
F:OND

Watchlist Manager
Oncopeptides AB Logo
Oncopeptides AB
F:OND
Watchlist
Price: 0.1712 EUR 3.01%
Market Cap: €36.2m

Wall St Price Targets

OND Price Targets Summary
Oncopeptides AB

Wall Street analysts forecast OND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OND is 0.6621 EUR with a low forecast of 0.5316 EUR and a high forecast of 0.8565 EUR.

Lowest Forecast
Price Target
0.5316 EUR
210% Upside
Average Forecast
Price Target
0.6621 EUR
287% Upside
Highest Forecast
Price Target
0.8565 EUR
400% Upside
Oncopeptides AB Competitors:
Price Targets
KRNY
Kearny Financial Corp
11% Upside
FBIZ
First Business Financial Services Inc
13% Upside
HCAT
Health Catalyst Inc
9% Upside
EBMT
Eagle Bancorp Montana Inc
11% Upside

Revenue
Forecast

N/A
Past Growth
73% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
73% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 73%.

Gross Profit
Forecast

N/A
Past Growth
102% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
102% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

The compound annual growth rate for Gross Profit over the next 2 years is 102%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OND's stock price target?
Price Target
0.6621 EUR

According to Wall Street analysts, the average 1-year price target for OND is 0.6621 EUR with a low forecast of 0.5316 EUR and a high forecast of 0.8565 EUR.

What is the Revenue forecast for Oncopeptides AB?
Projected CAGR
73%

The compound annual growth rate for Revenue over the next 3 years is 73%.

What is the Gross Profit forecast for Oncopeptides AB?
Projected CAGR
102%

The compound annual growth rate for Gross Profit over the next 2 years is 102%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett